Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
274 studies found for:    "Breast cancer male"
Show Display Options
Rank Status Study
1 Recruiting Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients
Condition: Male Breast Cancer
Interventions: Drug: Tamoxifen;   Drug: Tamoxifen and GnRH analogue;   Drug: Exemestane and GnRH analogue
2 Active, not recruiting Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).
Condition: Male Breast Cancer
Intervention:
3 Completed Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007
Condition: Breast Cancer
Intervention:
4 Recruiting Sense of Hope Alleviates Fatigue in Breast Cancer Survivors
Condition: Carcinoma of Male Breast
Intervention:
5 Recruiting Male Breast Cancer: Understanding the Biology for Improved Patient Care
Condition: Breast Cancer
Intervention:
6 Active, not recruiting Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens
Conditions: Female Breast Cancer;   Male Breast Cancer
Interventions: Procedure: Bilateral mastectomy;   Other: Biopsy
7 Active, not recruiting
Has Results
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: vorinostat;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Procedure: positron emission tomography;   Radiation: F-18 16 alpha-fluoroestradiol;   Radiation: fludeoxyglucose F 18;   Other: laboratory biomarker analysis
8 Active, not recruiting
Has Results
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: vorinostat;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Radiation: F-18 16 alpha-fluoroestradiol;   Procedure: positron emission tomography;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Genetic: gene expression analysis
9 Active, not recruiting Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: vorinostat;   Drug: ixabepilone;   Other: laboratory biomarker analysis;   Other: pharmacological study
10 Active, not recruiting
Has Results
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: cixutumumab;   Drug: temsirolimus;   Other: laboratory biomarker analysis
11 Completed Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: pazopanib hydrochloride;   Procedure: pharmacological study;   Procedure: laboratory biomarker analysis
12 Completed
Has Results
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: cediranib maleate;   Other: laboratory biomarker analysis
13 Terminated
Has Results
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: vorinostat;   Other: laboratory biomarker analysis
14 Completed FR901228 in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: romidepsin;   Other: laboratory biomarker analysis
15 Completed Sorafenib in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
16 Terminated 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: triapine;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacological study
17 Terminated Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: recombinant vaccinia-MUC1 vaccine;   Biological: recombinant vaccinia-TRICOM vaccine;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
18 Completed
Has Results
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: GTI-2040;   Drug: capecitabine
19 Completed Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
20 Completed Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer
Conditions: Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: trastuzumab;   Drug: gefitinib;   Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.